Schonfeld Strategic Advisors’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Sell |
930,809
-6,863,704
| -88% | -$7.69M | 0.01% | 1207 |
|
|
2025
Q1 | $6.16M | Buy |
+7,794,513
| New | +$6.16M | 0.04% | 413 |
|
|
2024
Q2 | – | Sell |
-886,925
| Closed | -$6.51M | – | 2106 |
|
|
2024
Q1 | $6.51M | Buy |
886,925
+389,468
| +78% | +$2.86M | 0.04% | 459 |
|
|
2023
Q4 | $1.86M | Buy |
497,457
+478,257
| +2,491% | +$1.79M | 0.01% | 759 |
|
|
2023
Q3 | $40.7K | Buy |
+19,200
| New | +$40.7K | ﹤0.01% | 1403 |
|
|
2023
Q1 | – | Sell |
-139,000
| Closed | -$1.4M | – | 2156 |
|
|
2022
Q4 | $1.4M | Buy |
139,000
+54,144
| +64% | +$546K | 0.01% | 979 |
|
|
2022
Q3 | $1.9M | Sell |
84,856
-15,736
| -16% | -$353K | 0.02% | 883 |
|
|
2022
Q2 | $2.49M | Buy |
+100,592
| New | +$2.49M | 0.02% | 631 |
|
|
2021
Q1 | – | Sell |
-4,117
| Closed | -$375K | – | 1835 |
|
|
2020
Q4 | $375K | Sell |
4,117
-4,996
| -55% | -$455K | 0.01% | 1092 |
|
|
2020
Q3 | $364K | Buy |
+9,113
| New | +$364K | 0.01% | 982 |
|
|
2019
Q4 | – | Sell |
-96,400
| Closed | -$1.5M | – | 1327 |
|
|
2019
Q3 | $1.5M | Buy |
96,400
+85,035
| +748% | +$1.32M | 0.04% | 378 |
|
|
2019
Q2 | $231K | Buy |
+11,365
| New | +$231K | 0.01% | 848 |
|
|
2018
Q4 | – | Sell |
-116,100
| Closed | -$1.89M | – | 1116 |
|
|
2018
Q3 | $1.89M | Buy |
+116,100
| New | +$1.89M | 0.08% | 293 |
|